GO2 is at the forefront of everything that’s happening in lung cancer. We’re the go-to for one-on-one assistance, supportive connections, screening and treatment information, and finding the best care close to home. We’re the place to go to learn about the latest research and special initiatives that increase survivorship. We’re the source for improving health policies and leading public awareness to shift this disease from one of stigma to one of hope. We are teachers, guides, advocates and supporters. Confronting lung cancer starts here.
March 06, 2025
Video
The FDA has approved Imfinzi for some adults with limited-stage small cell lung cancer.
March 06, 2025
Video
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung cancer.
March 06, 2025
Video
The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 gene fusion.
March 06, 2025
Video
On the heels of two FDA approvals in lung cancer treatments, what innovations are next?